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Objectives. This study aims to assess the beliefs and fears of patients about this technique before its application. Besides it
analyzes the clinical symptoms of anxiety and depression associated.
Methods. Prospective and longitudinal study, with two measurement times (before RT application and after). Was performed in
Group IMO Foundation with a sample of 50 patients with various oncology diseases, undergoing conventional radiotherapy. The
assessment procedure was: (a) ad hoc questionnaire beliefs about radiotherapy; (b) anxiety and clinical depression questionnaire,
and (c) satisfaction with the information received scale. Analysis: It will be a descriptive analysis of the characteristics of the
population-level sociodemographic, clinical and satisfaction with the information. It will apply a correlation analysis between
symptoms of anxiety and depression and beliefs about RT. On the other hand, it will use a nonparametric test (Wilcoxon) to
determine the change in beliefs about RT and anxiety-depression.
Conclusions. Adequate information on cancer treatments reduces uncertainty, promotes treatment compliance and minimizes
stress (Cruzado, 2010). It is therefore important not only explain the medical procedure but also the reason for using the same
and the effects produced (Cruzado and Olivares, 2005).
http://dx.doi.org/10.1016/j.rpor.2013.03.589
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Introduction. There has been growing evidence during the last decade on the beneﬁts of physical exercise as an intervention to
control cancer related side effects such as cancer related fatigue (CRF) and pain. Nordic Walking (NW) is a physical activity with
great physiological and psychosocial advantages over more traditional aerobic types of exercise such as walking or running. It
consists on adding a pair of speciﬁc poles, that help propel the body forward, to the normal walking pattern. In this way the work
of the upper and lower body is integrated in a symmetric and balanced way.
Objectives. To determine the potential beneﬁts from NW as a physical exercise indicated for patients undergoing radiotherapy.
Methodology Literature review.
Results. NW signiﬁcantly increases oxygen consumption, heart rate and energy expenditure when compared to normal walking at
the same speed, however, and due to the effort being spread between the upper and lower body, the perceived exertion remains
low. NW can therefore result in signiﬁcant physiological beneﬁts without increased perceived exertion. This is particularly
relevant when considering adherence to exercise programs.
Conclusions. NW as an intervention to improve the physical ﬁtness of patients undergoing radiotherapy can potentially result
in better physiological outcomes when compared to other forms of aerobic exercise. Moreover, it is related to lower perceived
exertion which can palliate the poor adherence to exercise programs. There is a need for randomized controlled trials using NW
as an intervention in order to produce evidence and inform future practice.
http://dx.doi.org/10.1016/j.rpor.2013.03.590
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Introduction. Women with breast cancer might develop psychological distress including anxiety and depression during diagnosis
and treatment and after treatment. Most women’s lives change as well as their perspectives on and appreciation of life.
Objectives. The purpose of this study was to examine the experiences of breast cancer patients during adjuvant radiotherapy.
Materials and methods. Women with radiotherapy breast cancer at the Hospital “Puerta del Mar”, Cadiz, in October 2012 were
included in the study. We asked them to provide written informed consent. We used a psychosocial impact test developed by the
Department of Medical Oncology at the University Hospital Marques de Valdecilla, Santander. Answers evaluation: depression
and anxiety test >5 needs psychological support. Twenty-ﬁve patient consented to participate in the study. They answered the
questionnaires in privacy and they could choose the questions they wanted to answer. Patients age was 53.91 years (36–81). Level
of education: primary: 44%, secondary: 32%. Coping with the disease and treatment: Acceptance: 28% (7/25). Active coping: 28%.
Resignation: 28%. Principal carer: Partner 40% (8/25), family 40%.
Results. Trait depression, score from 0/10: 0: 44%, < 5: 72% (18/25); ≥5: 28% (7/25). Trait Anxiety: 0: 32%; <5: 84%; ≥5: 16%. Ques-
tionnaires: Have you felt pain?: No/low: 84%. Have you felt nauseated?: No: 96%. Were you tired?: No: 64%. Have you had trouble
sleeping?: No: 64%. Do you feel nervous? No: 72%. Were you worried?: No: 84%. Did you feel irritable?: No: 84%. Does it affect your
family life?: No: 80. Does it affect your sex life?: No: 60%. Pretty/a lot: 20%, NS/NC: 20%.
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Conclusions. Patients diagnosed as having breast cancer were neither depressed nor anxious during adjuvant radiotherapy.
Sexuality is the most affected issue of quality of life (40%). We will develop sexuality workshops as an area of improvement.
http://dx.doi.org/10.1016/j.rpor.2013.03.591
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Objective. The objective of this study is to assess the quality of life (QL) and mood in patients treated with radiotherapy.
Materials and methods. Descriptive, prospective, longitudinal single center pilot study approved by our center’s Ethical Committee
for Clinical Research. We obtained a sample of 40 patients with an estimated loss of 5 patients. Patient selection was carried out
from May to September 2012 in a consecutive, non-probabilistic manner. SPSS v15 was used for statistical analysis. The study
was performed using the EORTC QLQ-C30 test to evaluate QL and the HAD test to asses mood disorders. These two tests were
carried before and upon completion of the radiotherapy treatment.
Results. Of the 40 patients that began our study, 4 failed to complete the study due to lack of cooperation (3 patients) and exitus
(1 patient). Of the remaining 36, 15 (37%) were diagnosed with breast cancer, 12 (30%) with prostate cancer, 5 (13%) with head
and neck cancer and 4 (10%) with other locations. Mean age was 53 (24–82). By genders, 17 (42%) were women and 23 (58%)
were men. Of the tests carried out, only one parameter proved to be statistically signiﬁcant (p=0.041), the emotional function
of the QLQ-C30, with an initial value of 75.00 (22.91) and a ﬁnal value of 83.33 (16.67). All other parameters analyzed did not
reach statistical signiﬁcance. With a tendency in regard to P50, in the subscale of symptoms, pain (P50=25−16.67) and insomnia
(P50=16.67−0) showed a decrease upon treatment completion, whereas fatigue increased by the end of radiotherapy treatment
(P50=22.22–33.33). All other symptoms did not show any remarkable alterations.
Conclusions. Radiotherapy treatment represents a stress factor in the patient’s mood, worsening its emotional function and
therefore creating an adaptative response which leads to symptoms of anxiety and depression. In order to reach statistically
signiﬁcant differences in the other parameters assessed, a larger patient sample is needed.
http://dx.doi.org/10.1016/j.rpor.2013.03.592
Tolerability and effectiveness of OTFC in patients with radiation-induced oral mucositis
L. Zugazabeitia Olabarria
Policlínico Vigo, S.A. (povisa), Spain
Introduction. Oral mucositis is a common problem in cancer patients and it is often associated with treatment of radio and/or
chemotherapy. It is a painful condition, with great impact on the quality of life of patients and can lead to discontinuation of
treatment, with treatment failure that entails. OTFC is indicated for the treatment of breakthrough cancer pain and may be
beneﬁcial for the treatment of this condition.
Objectives. Assess the effectiveness and tolerability of OTFC in patients with oral mucositis induced by radiotherapy.
Methods. An open-label, prospective, observational study of the effectiveness of OTFC in 90 patients with grade 2–3 or 4 oral
mucositis, produced by radiation therapy. All of them were receiving concomitant chemotherapy (with platinum or taxanes). The
treatment was assessed by determining the degree of RT treatment interruption due to pain and the possibility of maintaining
nutritional support for the patient. Adverse effects attributable to OTFC were also reported.
Results. No patient discontinued RT treatment for pain. All patients were able to maintain the nutritional support. There were no
adverse effects attributable to OTFC.
Conclusions. OTFC can be considered a safe and effective option in the treatment of pain in these patients, avoiding treatment
interruptions and facilitating nutritional support.
http://dx.doi.org/10.1016/j.rpor.2013.03.593
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Purpose. To evaluate the results of the use of percutaneous endoscopic gastrostomy (PEG) during radiotherapy in patients with
head and neck cancer.
Materials and methods. We included 84 patients, 72 men and 12 women, mean aged 55 years (range 33–70), with head and neck
cancer, predominantly in the oropharynx; 82.14% were locally advanced (stages III–IV), and 17.86% in stages I–II. Radical 3D
radiotherapy was performed (September 2003–September 2010) with concurrent chemotherapy. Prophylactic PEG was indicated
